Evidence map›Paper›PMID 17913812›Full record

ArticleJournal of virology2007

Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.

Sabrina Cronier, Vincent Beringue, Anne Bellon, Jean-Michel Peyrin, Hubert Laude

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Mechanisms of prion-induced toxicity.Cell and tissue research · 2023
    Review
  5. Review
  6. Organoids for modeling prion diseases.Cell and tissue research · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Two distinct conformers of PrPActa neuropathologica communications · 2021
    Article
  12. Review
  13. Article
  14. Co-existence of PrPScientific reports · 2020
    Article
  15. The role of prion strain diversity in the development of successful therapeutic treatments.Progress in molecular biology and translational science · 2020
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sabrina CronierUnité de Virologie Immunologie Moléculaires, INRA, 78350 Jouy-en-Josas, France.
Vincent Beringue
Anne Bellon
Jean-Michel Peyrin
Hubert Laude
Virologie et Immunologie Moléculaires · FRCSL (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transmissible spongiform encephalopathies (TSE) arise as a consequence of infection of the central nervous system by prions and are incurable. To date, most antiprion compounds identified by in vitro screening failed to exhibit therapeutic activity in animals, thus calling for new assays that could more accurately predict their in vivo potency. Primary nerve cell cultures are routinely used to assess neurotoxicity of chemical compounds. Here, we report that prion strains from different species can propagate in primary neuronal cultures derived from transgenic mouse lines overexpressing ovine, murine, hamster, or human prion protein. Using this newly developed cell system, the activity of three generic compounds known to cure prion-infected cell lines was evaluated. We show that the antiprion activity observed in neuronal cultures is species or strain dependent and recapitulates to some extent the activity reported in vivo in rodent models. Therefore, infected primary neuronal cultures may be a relevant system in which to investigate the efficacy and mode of action of antiprion drugs, including toward human transmissible spongiform encephalopathy agents.

Indexed as

Amphotericin BAnimalsCells, CulturedChlorpromazineCongo RedCricetinaeHumansMiceMice, TransgenicNeuronsPrion DiseasesPrion ProteinsPrionsPrPC ProteinsPrPSc ProteinsScrapieAmphotericin BChlorpromazineCongo RedMS 8209Prion ProteinsPrionsPrnp protein, mousePrPC ProteinsPrPSc Proteins

Identifiers

PMID17913812
PMCPMC2168876
OpenAlexW2100615932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.